Fingerprint
Dive into the research topics of 'Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately or highly emetogenic chemotherapy: results of a prospective, randomized, double-blind, noninferiority phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically